Original Research
Published on 06 Mar 2023
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia
in Hematologic Malignancies
![Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia](https://www.frontiersin.org/files/myhome article library/1133418/1133418_Thumb_400.jpg)
- 1,854 views
- 3 citations